Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR5000 in advanced NSCLC
NCT00004151Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 1999
- Primary completion
- Nov 2000
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of acridine carboxamide in non-small cell lung cancer (NSCLC), sponsored by European Organisation for Research and Treatment of Cancer. Started Sep 1999; status: completed.
02
Drugs
acridine carboxamide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004151.